ROBERT KRANCE to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications ROBERT KRANCE has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.159
-
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study. Invest New Drugs. 1990 May; 8(2):167-70.
Score: 0.079
-
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 2000 Feb 15; 95(4):1502-5.
Score: 0.039
-
Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet. 1997 Sep 13; 350(9080):767-71.
Score: 0.033
-
Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Leukemia. 1997 Feb; 11(2):206-11.
Score: 0.008